DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Andtbacka RHI, Ross M, Puzanov I. et al.
Patterns of clinical response with Talimogene laherparepvec (T-VEC) in patients with melanoma treated in the OPTiM phase III clinical trial.
Ann Surg Oncol 2016;
23 (13) 4169-4177
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.